2016: Front page New York Times story explores Kite Pharma’s profitable relationship with NIH regarding expensive cancer drug
Matt Richtel and Andrew Pollack explore the complex policy issues involved with the pricing of products based on taxpayer-funded inventions and research in a front page New York Times story published today.